{"disease":{"id":"hepatoma","name":"hepatoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04567615","title":"A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":266,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT04920019","title":"Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT03638206","title":"Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":73,"lead_sponsor_name":"Shenzhen BinDeBio Ltd.","has_results":false},{"nct_id":"NCT06700564","title":"The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shanghai East Hospital","has_results":false},{"nct_id":"NCT03941626","title":"Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Shenzhen BinDeBio Ltd.","has_results":false},{"nct_id":"NCT04310709","title":"Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT07391839","title":"MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Suzhou Mednovo Yi Medical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT01306058","title":"Sorafenib and TRC105 in Hepatocellular Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00503867","title":"SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma","phase":"NA","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Sirtex Medical","has_results":true},{"nct_id":"NCT05035108","title":"The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Sir Run Run Shaw Hospital","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}